Leerink Partnrs Lowers Earnings Estimates for Schrödinger

Schrödinger, Inc. (NASDAQ:SDGR) – Research analysts at Leerink Partnrs decreased their FY2024 EPS estimates for shares of Schrödinger in a research note issued on Tuesday, November 12th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will earn ($1.99) per share for the year, down from their previous estimate of ($1.78). The consensus estimate for Schrödinger’s current full-year earnings is ($2.19) per share. Leerink Partnrs also issued estimates for Schrödinger’s Q4 2024 earnings at $0.03 EPS, FY2025 earnings at ($2.10) EPS, FY2026 earnings at ($2.44) EPS, FY2027 earnings at ($2.60) EPS and FY2028 earnings at ($0.89) EPS.

Several other equities research analysts also recently weighed in on the company. BMO Capital Markets upped their price target on Schrödinger from $25.00 to $28.00 and gave the stock an “outperform” rating in a report on Wednesday. Morgan Stanley lowered their price target on shares of Schrödinger from $43.00 to $30.00 and set an “equal weight” rating for the company in a report on Wednesday, August 21st. Three research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $32.90.

Schrödinger Stock Down 9.0 %

Shares of SDGR stock opened at $18.54 on Friday. Schrödinger has a 52 week low of $16.67 and a 52 week high of $38.00. The stock has a market capitalization of $1.35 billion, a PE ratio of -7.92 and a beta of 1.50. The firm has a 50 day moving average of $18.72 and a two-hundred day moving average of $20.35.

Schrödinger (NASDAQ:SDGR) last released its earnings results on Tuesday, November 12th. The company reported ($0.52) earnings per share for the quarter, missing the consensus estimate of ($0.40) by ($0.12). The firm had revenue of $35.30 million during the quarter, compared to analyst estimates of $41.25 million. Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The business’s revenue was down 17.1% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.86) earnings per share.

Insider Activity

In other Schrödinger news, insider Margaret Dugan sold 1,531 shares of Schrödinger stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $17.78, for a total value of $27,221.18. Following the transaction, the insider now directly owns 13,469 shares in the company, valued at approximately $239,478.82. This trade represents a 10.21 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 8.60% of the company’s stock.

Hedge Funds Weigh In On Schrödinger

A number of large investors have recently bought and sold shares of the company. Nisa Investment Advisors LLC boosted its holdings in Schrödinger by 145.3% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,413 shares of the company’s stock valued at $27,000 after purchasing an additional 837 shares in the last quarter. GAMMA Investing LLC increased its holdings in Schrödinger by 49.5% in the second quarter. GAMMA Investing LLC now owns 2,124 shares of the company’s stock valued at $41,000 after buying an additional 703 shares in the last quarter. KBC Group NV lifted its position in shares of Schrödinger by 45.4% during the 3rd quarter. KBC Group NV now owns 2,508 shares of the company’s stock valued at $47,000 after acquiring an additional 783 shares during the period. Quarry LP raised its holdings in Schrödinger by 1,150.0% during the third quarter. Quarry LP now owns 2,825 shares of the company’s stock worth $52,000 after purchasing an additional 2,599 shares during the last quarter. Finally, nVerses Capital LLC acquired a new stake in Schrödinger in the second quarter valued at $66,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.